Skip to main content
University of Maryland 1856

Home

  • About
    • Overview
    • Capabilities
    • People
    • Undergraduate Research Opportunities
    • Contact CESAR
  • EDDS
    • About EDDS
    • EDDS Hospitals - Current Data
    • EDDS Research Reports
  • CDEWS
    • About CDEWS
    • CDEWS Publications
  • Other Projects
    • National Drug Early Warning System (NDEWS)
    • Rural Opioid Technical Assistance (ROTA)
    • Opioid Misuse Prevention Program (OMPP) Evaluation
    • Completed Research
  • Publications
  • About
    • Overview
    • Capabilities
    • People
    • Undergraduate Research Opportunities
    • Contact CESAR
  • EDDS
    • About EDDS
    • EDDS Hospitals - Current Data
    • EDDS Research Reports
  • CDEWS
    • About CDEWS
    • CDEWS Publications
  • Other Projects
    • National Drug Early Warning System (NDEWS)
    • Rural Opioid Technical Assistance (ROTA)
    • Opioid Misuse Prevention Program (OMPP) Evaluation
    • Completed Research
  • Publications

Publications

Background abstract image
  • Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, OregonBilling, A.S., Artigiani, E.E, Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, Oregon. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Serenity-Lane-March-2019-Final.pdf1.06 MB
  • Using Electronic Health Records to Track Emerging Drug Problems in Baltimore (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA MPower_EpicBulletin_Feb2019_Revised_0.pdf443.65 KB
  • Using Hospital Electronic Health Records to Monitor Drug Use Trends in Overdose Patients (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA EDDS-EHR-MD-Baltimore-Feb2019.pdf443.61 KB
  • DEA Emerging Threat Report: Annual 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2018-Annual.pdf404.56 KB
  • DEA Emerging Threat Report: Fourth Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory DEA-Emerging-Threat-Report-2018-Quarter-4.pdf270.34 KB
  • DOTS Issue 8 - Methamphetamine and New Psychoactive Substances Detected in Specimens from Pretrial Services Agency for the District of Columbia dotsbulletin-issue8-october2018-dcpsa_0.pdf148.3 KB
  • DEA Emerging Threat Report: Third Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-3.pdf159.93 KB
  • Methamphetamine: A Regional Drug Crisis (2018)NDEWS Sentinel Community Epidemiologists ndews-scs-methamphetamine-report-september-2018-final_0.pdf1.16 MB
  • DOTS Issue 7 - Methamphetamine, but No Fentanyl, Found in Opiate-Positive Specimens from a Corpus Christi, Texas, Residential Treatment Center; Multiple Drugs Found in Every Specimen dotsbulletin-issue7-august2018-charliesplacetx-final_0.pdf299.55 KB
  • CDEWS Reports: Drug Early Warning from Re-Testing Biological Samples: Allen County, Indiana. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. Wish, E.D., Billing, A.S., and Artigiani, E.E. (2018) finalreport_cdews4_inv36.pdf1.82 MB
  • CDEWS Reports: Drug Early Warning from Re-Testing Biological Samples: Jefferson/Lincoln/Pulaski/Rockcastle Counties, Kentucky. Office of National Drug Control Policy. Washington, DC: Executive Office of the President.Wish, E.D., Billing, A.S., and Artigiani, E.E. (2018). finalreport_cdews4_kyv43.pdf1.93 MB
  • DEA Intelligence Report: Slang Terms and Code Words: A Reference for Law Enforcement Personnel (2018)Drug Enforcement Administration (DEA) dea-drug-slang-terms-and-code-words-july2018.pdf1.35 MB
  • DOTS Issue 5 - Uninsured Opioid Users Admitted to Medication-Assisted Treatment (MAT) Program in Palm Beach County, Florida, Found to Be Using Many Drugs in Addition to Opioids dots-bulletin-issue5-july2018-palmbeach-mat-final_0.pdf159.28 KB
  • DOTS Issue 6 - No Fentanyl Analogs but Buprenorphine, Naloxone, and Marijuana Detected in Specimens from Suspected Users of Fentanyl in Vermont dotsbulletin-issue6-july2018-aspenti-final_0.pdf121.62 KB
  • Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study; Office of National Drug Control Policy. Washington, DC: Executive Office of the President. Wish, E.D., Billing, A.S., Artigiani, E.E., Dezman, Z., Schwartz, B., and Pueschel, J. (2018). FinalReport_CDEWS4_ED_Maryland-Hospital-Study.pdf2.62 MB
  • DEA Emerging Threat Report: Mid Year 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-mid-year.pdf426.96 KB
  • DEA Emerging Threat Report: Second Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-2.pdf361.4 KB
  • DOTS Issue 1 - Overview of the Drug Outbreak Testing Service Pilot Study dotsbulletin-issue1-june2018-methodology-final_0.pdf97.59 KB
  • DOTS Issue 2 - First DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore – Higher Doses of Naloxone May Be Needed dotsbulletin-issue2-june2018-baltimore-midtown-final_0.pdf160.4 KB
  • DOTS Issue 3 - Methamphetamine, Opioids, Cocaine, and Multiple Drugs Were Most Common in Specimens from Seattle/King County Area Decedents dotsbulletin-issue3-june2018-kingcomedicalex-final_0.pdf190.22 KB
  • DOTS Issue 4 - Drug-Positive Urine Specimens from Uninsured or Publicly Insured Residents of Montgomery County, Maryland, Contain No Fentanyl and Few Synthetic Cannabinoids but Do Contain Multiple Drugs dotsbulletin-issue4-june2018-accesstobh-final_0.pdf128.54 KB
  • First DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore – Higher Doses of Naloxone May Be Needed; DOTS Bulletin Issue 2Zachary D.W. Dezman, MD, Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, Marwa F. Al-Nassir, BS; Amy S. Billing, MSSA; E. Erin Artigiani, MA; and Eric D. Wish, PhD, Center for Substance Abuse Research, Uni dotsbulletin-issue2-june2018-baltimore-midtown-final.pdf160.4 KB
  • DEA Emerging Threat Report: First Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-1.pdf1.16 MB
  • Methamphetamine: A Regional Drug Crisis. College Park, MD: National Drug Early Warning System. (2018)Artigiani, E.E., Hsu, M.H., McCandlish, D., and Wish, E.D. ndews-scs-methamphetamine-report-september-2018-final.pdf1.16 MB
  • DEA Emerging Threat Report: Annual 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-annual.pdf1.47 MB

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Center for Substance Abuse Research (CESAR)
University of Maryland, College Park, Maryland
*Contact us for mailing address
Phone: 301-405-9770 ♦ Email: cesar [at] umd.edu ♦ Contact Us
Privacy Policy & Disclaimers ♦ Green Office  ♦ PTK Policy 

  • College Directory
  • Alumni
  • UMD Web Accessibility
University of Maryland 1856 - College of Behavioral & Social Sciences

Login / Logout